Testing strategies in multi-dose experiments including active control

Statistics in Medicine

Volumn 17, Issue 18, 1998, Pages 2133-2146

  Bauer, P ^a   Rohmel J ^b   Maurer, W ^c   Hothorn, L ^d  

^a UNIVERSITY OF VIENNA   (Austria)

^b Bundesinstitut Arzneimittel M   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

^d LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; DRUG; HYDROQUINONE; PLACEBO;

ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MUTAGEN TESTING; STATISTICAL ANALYSIS;

ALKYLATING AGENTS; AMLODIPINE; ANGINA PECTORIS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CONTROLLED CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROQUINONES; MICRONUCLEUS TESTS; MODELS, STATISTICAL; MUTAGENS; PHARMACEUTICAL PREPARATIONS; PLACEBOS; RADIATION-PROTECTIVE AGENTS; SAMPLE SIZE; TERATOGENS;

EID: 0032582081     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19980930)17:18<2133::AID-SIM901>3.0.CO;2-2     Document Type: Article

References (32)

1. D'Agostino, R. B. and Heeren, T. C. 'Multiple comparisons in over the counter drug clinical trials with both positive and placebo controls', Statistics in Medicine, 10, 1-6 (1991).
2. Dunnett, C. W. and Tamhane, A. C. 'Comparison between a new drug and active and placebo controls in an efficacy clinical trial', Statistics in Medicine, 11, 1057-1063 (1992).
3. D'Agostino, R. B., Massaro, J., Hwan, H. and Cabral, H. 'Strategies for dealing with multiple comparisons in confirmatory clinical trials', Drug Information Journal, 27, 625-641 (1993).
4. Maurer, W., Hothorn, L. A. and Lehmacher, W. 'Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses', in Vollmar, J. (ed.), Biometrie in der chemisch-pharmazeutischen Biometrie, Vol. 6, Fischer Verlag, Stuttgart, 1995, pp. 3-18.
5. Koch, G. G. 'Comment', Statistics in Medicine, 10, 13-16 (1991).
6. Sonnemann, E., Finner, H. and Kunert, J. 'Analyse von Verlaufskurven', Biometriekurs, Universität Trier, 1986.
7. Bauer, P. 'Multiple testing in clinical trials', Statistics in Medicine, 10, 871-890 (1991).
8. Marcus, R., Peritz, E. and Gabriel, K. R. 'On closed testing procedures with special reference to ordered analysis of variance', Biometrika, 63, 655-660 (1976).
9. Hochberg, Y. and Tamhane, A. C. Multiple Comparison Procedures, Wiley, New York, 1987.
10. Dunnett, C. W. 'A multiple comparison procedure for comparing several treatments with a control', Journal of the American Statistical Association, 50, 1096-1121 (1955).
11. Berger, R. L. 'Multiparameter hypothesis testing and acceptance sampling', Technometrics, 24, 295-300 (1982).
12. Casella, G. and Berger, R. L. Statistical Inference, Wadsworth & Brooks, Pacific Grove, 1990.
13. Dunnett, C. W. and Tamhane, A. C. 'Step-down multiple tests for comparing treatments with a control in unbalanced one-way layout', Statistics in Medicine, 10, 939-947 (1991).
14. Naik, U. D. 'Some selection rules for comparing p processes with a standard', Communications in Statistics - Theory and Methods, 4, 519-535 (1975).
15. Hothorn, L. A. 'Biostatistical analysis of experimental designs with a positive control group in toxicology', in Vollmar, J. (ed.), Biometrie in der chemisch-pharmazeutischen Biometrie, Vol. 6, Fischer Verlag, Stuttgart, 1995, pp. 19-26.
16. Westfall, P. H. and Young, S. S. Resampling-Based Multiple Testing, Wiley, 1993.
17. Bartholomew, D. J. 'A test of homogeneity for ordered alternatives', Biometrika, 46, 34-38 (1959).
18. Williams, D. A. 'A test for difference between treatment means when several dose levels are compared with a zero dose control', Biometrics, 27, 103-117 (1971).
19. Williams, D. A. 'The comparison of several dose levels with a zero dose control', Biometrics, 28, 519-531 (1972).
20. Jonckeere, A. R. 'A distribution-free k-sample test against ordered alternatives', Biometrika, 41, 133-145 (1954).
21. 2 tests', Biometrics, 10, 417-451 (1954).
22. Armitage, P. 'Tests for linear trends in proportions and frequencies', Biometrics, 11, 375-386 (1955).
23. Hauschke, D. 'Testprinzipien bei "Safety"-Studien in der Toxikologie', in Trampisch, H. J. and Lange, S. (eds), Medizinische Forschung und ärztliches Handeln, Biometrie und Epidemiologie, Vol. 80, MVM Medizin Verlag, München, 1995, pp. 104-107.
24. Neuhäuser, M. and Hothorn, L. A. 'Auswertung der Dosis-Wirkungs-Abhängigkeit des Ames Mutagenitätsassay bei direkter Kontrolle des Konsumentenrisikos', in Trampisch, H. J. and Lange, S. (eds), Medizinische Forschung und ärztliches Handeln, Biometrie und Epidemiologie, Vol. 80, MVM Medizin Verlag, München, 1995, pp. 113-116.
25. Budde, M. and Bauer, P. 'Multiple test procedures in clinical dose finding studies', Journal of the American Statistical Association, 84, 792-796 (1989).
26. Lee, R. E. and Spurrier, J. D. 'Successive comparisons between ordered treatments', Journal of Statistical Planning and Inference, 43, 323-330 (1995).
27. Adler, I.-D. and Kliesch, U. 'Comparison of single and multiple treatment regiments in the mouse bone marrow micronucleus assay for hydroquinone and cyclophosphamide', Mutation Research, 234, 115-123 (1990).
28. Holm, S. A. 'A simple sequentially rejective multiple test procedure', Scandinavian Journal of Statistics, 6, 65-70 (1979).
29. Sonnemann, E. 'Allegemeine Lösung multipler Testprobleme', EDV in Medizin und Biologie, 13, 120-128 (1982).
30. Bauer, P. and Kieser, M. 'A unifying approach for confidence intervals and testing of equivalence and difference', Biometrika, 83, 934-937 (1996).
31. Morikawa, T. and Yoshida, M. 'A useful testing strategy in phase III trails: Combined test of superiority and test of equivalence', Journal of Biopharmaceutical Statistics, 5, 297-306 (1995).
32. Röhmel, J. and Streitberg, B. 'Zur Konstruktion globaler Tests', EDV in Medizin und Biologie, 18, 7-11 (1987).